The Subcutaneous Revolution: Zymfentra and the Future of IBD Care With Dr Andres Yarur
Season 6, Episode 22, Dec 17, 2023, 12:00 PM
On this episode of Not So Different, Andres Yarur, MD, a researcher and associate professor of medicine at Cedars-Sinai Medical Center, discusses the significance of the FDA approval for Zymfentra, the world's first subcutaneous infliximab product, for patients with inflammatory bowel disease (IBD).
Show notes
To learn more about the FDA approval of Zymfentra, click here.
To learn more about the results from the LIBERTY trials, click here.
To learn more about the results from the LIBERTY trials, click here.